• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Growth Hormone Deficiency - Pipeline Review, Q4 2010 - Product Image

Growth Hormone Deficiency - Pipeline Review, Q4 2010

  • Published: December 2010
  • 48 pages
  • Global Markets Direct

Growth Hormone Deficiency - Pipeline Review, Q4 2010

Summary

Global Markets Direct’s, “Growth Hormone Deficiency    Pipeline Review, Q4 2010”, provides an overview of the Growth Hormone Deficiency    therapeutic pipeline. This report provides information on the therapeutic development for Growth Hormone Deficiency   , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency   . “Growth Hormone Deficiency   -Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- A snapshot of the global therapeutic scenario for Growth Hormone Deficiency   .
- A review of the Growth Hormone Deficiency    products under development by companies READ MORE >



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Growth Hormone Deficiency Overview
Therapeutics Development
An Overview of Pipeline Products for Growth Hormone Deficiency
Growth Hormone Deficiency Therapeutics under Development by Companies
Growth Hormone Deficiency Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Companies Involved in Growth Hormone Deficiency Therapeutics Development
Ipsen S.A.
Dong-A Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Limited
Merck KGaA
AEterna Zentaris Inc.
PROLOR Biotech, Inc.
Neuren Pharmaceuticals Limited
Theratechnologies Inc.
LG Life Sciences, Ltd
Critical Pharmaceuticals Limited
Ambrx, Inc.
Phage Biotechnology Corporation
Versartis, Inc.
Genexine Co., Ltd.
Althea Technologies, Inc.
PharmaEssentia Corporation
Ascendis Pharma A/S
Universities/Institutes Involved in Growth Hormone Deficiency Therapeutics Development
Growth Hormone Deficiency Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles – Companies
ALTU-238 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LB03002 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Solorel - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Late Stage Drug Profiles – Universities/Institutes
Arimidex - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Discontinued Products
Growth Hormone Deficiency - Featured News
Oct 05, 2010: PROLOR Biotech Receives FDA Orphan Status For hGH-CTP For Treatment Of Growth Hormone Deficiency
Oct 05, 2010: Aeterna Zentaris Reports AEZS-130 Phase III Data Analysis Shows Potential For Filing As Oral Diagnostic Test For Adult Growth Hormone Deficiency
Aug 24, 2010: PROLOR Receives FDA Clearance For Phase II Trial Of Human Growth Hormone In US
Aug 02, 2010: PROLOR Announces Publication Of Preclinical Study Of hGH-CTP In Journal Endocrinology
Jul 21, 2010: PROLOR Biotech Initiates Phase II Clinical Trial Of Human Growth Hormone
Jun 21, 2010: Aeterna Zentaris Presents Positive Data On AEZS-130 At ENDO Meeting
Oct 14, 2009: Critical Pharmaceuticals Secures £1.5m From Wellcome Trust To Develop hGH Nasal Spray
Oct 01, 2008: Critical Pharmaceuticals Enter Sustained Release hGH Arena With CP016
Jul 10, 2007: Tercica Announces Agreement With Genentech For Worldwide Growth Hormone And IGF-1 Combination Product Development And Commercialization
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos